PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Center for Global Infectious Disease Research, Seattle Children\'s Research Institute, Seattle, WA, United States.\', \'Department of Pediatrics, University of Washington, Seattle, WA, United States.\', \'Department of Global Health, University of Washington, Seattle, WA, United States.\', \'Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.791764
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34868082
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all